Should central venous catheter be systematically removed in patients with suspected catheter related infection? by unknown
Lorente et al. Critical Care 2014, 18:564
http://ccforum.com/content/18/5/564RESEARCH Open AccessShould central venous catheter be systematically
removed in patients with suspected catheter
related infection?
Leonardo Lorente1*, María M Martín2, Pablo Vidal3, Sergio Rebollo4, María I Ostabal5, Jordi Solé-Violán6
and Working Group on Catheter Related Infection Suspicion Management of GTEIS/SEMICYUCAbstract
Introduction: Best clinical practice for patients with suspected catheter-related infection (CRI) remains unclear
according to the latest Infectious Diseases Society of America (IDSA) guidelines. Thus, the objective of this study
was to analyze clinical practice concerning the central venous catheter (CVC) and its impact on prognosis in
patients with suspected CRI.
Methods: We performed a prospective, multicenter, observational study in 18 Spanish Intensive Care Units (ICUs).
Inclusion criteria were patients with CVC and suspected CRI. The following exclusion criteria were used: age less
than 18 years; pregnancy; lactation; human immunodeficiency virus; neutropenia; solid or haematological tumor;
immunosuppressive or radiation therapy; transplanted organ; intravascular foreign body; haemodynamic instability;
suppuration or frank erythema/induration at the insertion site of the CVC, and patients with bacteremia or
fungemia. The end-point of the study was mortality at 30 days of CRI suspicion.
Results: The study included 384 patients. In 214 (55.8%) patients, CVC was removed at the moment of CRI
suspicion, in 114 (29.7%) CVC was removed later and in 56 (14.6%) CVC was not removed. We did not find
significant differences between survivors (n =311) and non-survivors (n =73) at 30 days according to CVC decision
(P =0.26). The rate of confirmed catheter-related bloodstream infection (CRBSI) was higher in survivors than in
non-survivors (14.5% versus 4.1%; P =0.02). Mortality rate was lower in patients with CRBSI than in the group of
patients whose clinical symptoms were due to other causes (3/48 (6.25%) versus 70/336 (20.8%); P =0.02). We did
not find significant differences in mortality in patients with confirmed CRBSI according to CVC removal at the
moment of CRI suspicion (n =38) or later (n =10) (7.9% versus 0; P =0.99).
Conclusion: In patients with suspected CRI, immediate CVC removal may be not necessary in all patients. Other
aspects should be taken into account in the decision-making, such as vascular accessibility, the risk of mechanical
complications during new cannulation that may be life-threatening, and the possibility that the CVC may not be
the origin of the suspected CRI.Introduction
Clinical practice guidelines for the management of intra-
vascular catheter-related infection (CRI) by the Infectious
Diseases Society of America (IDSA) are unclear on what
strategy to adopt in patients with central venous catheter
(CVC) and suspected CRI [1]. There are arguments in
favour of and against immediate CVC removal on suspicion* Correspondence: lorentemartin@msn.com
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unless otherwise stated.of CRI. On the one hand, catheter-related bloodstream
infection (CRBSI) has been associated with increased
mortality [2] and delayed CVC removal could lead to
worse prognosis if the focus of infection is the CVC
itself [3]. On the other hand, there are arguments against
immediate CVC removal when CRI is suspected.
First, one reason to suspect CRI is the presence of
fever, but critically ill patients frequently develop fever
and the cause is not always CRBSI; there are many other
causes of fever, including non-infectious processes (such
as pancreatitis, pulmonary infarction or acute respiratoryl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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(pneumonia, urinary tract infection and central nervous
system infection) [4]. Second, the incidence of CRBSI
has decreased due to the implementation of evidence-
based clinical practice during CVC insertion and mainten-
ance [5,6]. Third, in a randomized clinical trial involving
64 patients with suspected CRI, there were no differences
in outcome between groups with early CVC removal and
those with watchful waiting; however, in the watchful-
waiting group, only 38% underwent catheter removal [7].
Fourth, vascular catheterization by new puncture entails
the risk of serious and even life-threatening mechanical
complications such as vascular lesion, haematoma, hae-
mothorax, pneumothorax, nerve injury and gas embolism
[8]. The objective of this study was to analyze clinical
practice for CVC management in critically ill patients with
suspected CRI, and its impact on patient prognosis.
Methods
Design and subjects
We performed a prospective, observational, multicentre
study in 18 Spanish ICUs. The study was approved by the
Institutional Ethic Review Boards of the 18 participating
hospitals (Review Boards are listed in Acknowledgements).
Written informed consent from the patients or from their
family members was obtained.
Inclusion criteria were ICU patients with CVC and
suspected CRI. CRI was suspected when a patient devel-
oped a new episode of fever or sepsis. Fever was consid-
ered as temperature ≥38°C. Sepsis was defined according
to the International Sepsis Definitions Conference criteria
[9]. Exclusion criteria were: age <18 years, pregnancy, lac-
tation, HIV, neutropenia (<1000/mm3), solid or haemato-
logical tumor, immunosuppressive or radiation therapy,
transplanted organ, intravascular foreign body (for ex-
ample, pace-maker, prosthetic heart valve), haemodynamic
instability (start of norepinephrine to maintain adequate
blood pressure or increase of dose with 0.25 μg · kg · min
over the preceding 12 h), suppuration or frank erythema/
induration at the insertion site of the CVC, patients with
bacteraemia or fungemia, and tunneled catheters. The
decision about choice of immediate CVC removal or
watchful waiting was made by the physician responsible
for each patient.
Variables recorded
The following variables were recorded for each patient:
Age, sex, diagnosis on admission, diabetes mellitus, chronic
obstructive pulmonary disease (COPD), steroids, antibi-
otics, tracheostomy, temperature, leukocytes, neutrophils,
pressure of arterial oxygen/fraction inspired of oxygen
(PaO2/FIO2), platelets, activated partial thromboplastin
time (aPTT), international normalized ratio (INR), sepsis-
related organ failure assessment (SOFA) score [10], lacticacid, bilirubin, creatinine, CVC decision at moment of
CRI suspicion, moment of CVC removal, and cause of
symptoms.
End point
The end point of the study was mortality at 30 days after
suspicion of CRI.
Definitions
CVC-related bacteraemia (CVCB) was defined as a
positive blood culture by recognized pathogen (or two
positive blood cultures by skin contaminant microor-
ganism) obtained from a peripheral vein, and catheter-tip
colonization or positive conservative cultures for diagnosis
of CVCB (superficial cultures, quantitative blood cultures
or differential time to positivity) with the same organism
as the blood culture (the same species and identical anti-
microbial susceptibility).
Catheter-tip colonization was considered as significant
growth of a microorganism on the CVC tip (>15 colony-
forming units). Superficial cultures were considered to
be positive when the same microorganism (>15 colony-
forming units per plate) was isolated in cultures of skin
and/or catheter hubs and in peripheral blood. Quanti-
tative blood cultures were defined as positive when the
number of colony-forming units of microorganisms iso-
lated per milliliter of catheter-drawn blood was at least
three times greater than that of blood obtained from a
peripheral vein. Differential time to positivity was defined
as positive when the blood through any of the CVC hubs
yielded positive results at least 120 minutes earlier than
the positivity of a blood sample drawn simultaneously
from a peripheral vein. Primary bacteraemia (PB) was
defined as a positive blood culture obtained from a
peripheral vein, no apparent source of bacteraemia and
disappearance of symptoms within 48 hours after removal
of the venous catheter. CRBSI included the presence of
CVCB or PB.
Statistical analysis
Continuous variables are reported as means and standard
deviations, and categorical variables as frequencies and
percentages. We used the Mann-Whitney t-test to com-
pare continuous variables between groups. Comparison of
categorical variables between groups was performed using
the chi-square test. We carried out a propensity analysis
with logistic regression to control for the effect of sex,
admission diagnosis, COPD, SOFA score and CRBSI as
the cause of clinical symptoms at the moment of CVC
removal. The dependent variable was moment of CVC re-
moval, and the independent variables were sex, admission
diagnosis, COPD, SOFA score and CRBSI as the cause of
the symptoms. To control for the confounding impact of
propensity scores in mortality, we included propensity
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regression model. Risk ratio and 95% confidence intervals
were calculated as measures of the clinical impact of the
predictor variables. P-values <0.05 were considered statis-
tically significant. Statistical analysis was performed with
SPSS 17.0 (SPSS Inc., Chicago, IL, USA).
Results
The study included 384 patients with CVC and suspected
CRI, of whom 73 (19.0%) had died at 30 days of suspected
CRI. The causes of clinical symptoms were as follows: 48
patients (12.5%) with CRBSI, 101 (26.0%) with pneumonia,
60 (15.6%) with tracheobronchitis, 27 (7.0%) with urinary
infection, 21 (5.5%) with skin infection, 2 (0.5%) with
osteomyelitis, 4 (1.0%) with central nervous system in-
fection, 27 (7.0%) with abdominal infection, 1 (0.3%) with
otitis, 7 (1.8%) with non-infectious causes, 86 (22.4%) with
unknown causes. The seven patients with non-infectious
causes had the following: pancreatitis (n =3), mesenteric
ischemia (n =2), deep venous thrombosis (n =1) and
pulmonary thromboembolism (n =1).
Figure 1 shows the flowchart of patients included in
the study regarding CVC decision and 30-day mortality.
In 214 patients (55.8%) the CVC was removed immedi-
ately on suspicion of CRI. In 170 (44.3%) patients the
strategy of watchful waiting was adopted, with CVC main-
tained and microbiology cultures performed. Of the 214
patients whose CVC was removed immediately on suspi-
cion of CRI, in 180 patients a new CVC was canalized and
in 34 patients a new CVC catheter was not needed; and of
those 214 patients, 46 (21.5%) had died at 30 days after
suspected CRI. Of the 170 patients whose CVC was main-
tained along with microbiology cultures, in 56 patientsFigure 1 Characteristics of patients with suspected catheter-related in
catheter (CVC) and 30-day mortality.conservative cultures were performed for the diagnosis of
CRBSI (superficial cultures, quantitative blood cultures or
differential time to positivity) and in 114 patients these
conservative cultures were not performed. And in those
170 patients whose CVC was initially maintained, the
CVC was removed later in 54 patients, 7 (13.0%) had died
at 30 days. In 116 patients the CVC was not removed and
20 (17.2%) had died at 30 days after suspected CRI.
In the 54 patients in whom the catheter was not
initially removed, the reasons for later CVC removal
were the following: 45 (83.3%) had persistent fever, 5
(9.3%) persistent sepsis, 3 (5.6%) bloodstream infections
and 1 (1.9%) had suppuration at the insertion site.
Mean time from suspected CRI to catheter removal was
3.9 ± 2.5 days.
Table 1 shows comparisons of demographic and
clinical parameters between 30-day surviving (n =311)
and non-surviving (n =73) patients at the moment of
suspected CRI. We found that 30-day non-surviving pa-
tients showed higher SOFA score and lactic acid levels
than survivors at the time of suspected CRI. We did not
find significant differences between survivors and non-
survivors in CVC decision (P =0.26) and the moment of
CVC removal (P =0.31). In addition, the rate of con-
firmed CRBSI was higher in 30-day survivors than in
non-survivors (14.5% versus 4.1%; P =0.02).
Mortality rate at 30 days after suspected CRI was
lower in patients with CRBSI than in the group of pa-
tients whose clinical symptoms were due to other causes
(3/48 (6.25%) versus 70/336 (20.8%); P =0.02). However,
there were no statistically significant differences in SOFA
score (5 (2 to 7) versus 5 (3 to 8); P = 0.48) or lactic acid
levels (1.3 (1.0 to 1.9) versus 1.2 (0.9 to 1.8); P =0.74) atfection (CRI) according to decision on removal of central venous
Table 1 Characteristics of 30-day survivor and non-survivor patients
Data Survivors (n =311) Non-survivors (n =73) P-value
Age, years, median (percentile 25 to 75) 61 (50 to 71) 71 (59 to 76) 0.44
Sex, female, n (%) 210 (67.5) 43 (58.9) 0.17
Admission diagnostic, n (%) 0.15
Medical 203 (65.3) 56 (76.7)
Surgical 81 (26.0) 14 (19.2)
Traumatology 27 (8.7) 3 (4.1)
Diabetes mellitus, n (%) 75 (24.1) 22 (30.1) 0.30
Chronic obstructive pulmonary disease, n (%) 39 (12.5) 17 (23.3) 0.03
Corticosteroids, n (%) 55 (17.7) 17 (23.3) 0.32
Antibiotics, n (%) 225 (72.3) 56 (76.7) 0.56
Tracheostomy, n (%) 54 (17.4) 17 (23.3) 0.24
Temperature, °C, median (percentile 25 to 75) 38.0 (37.8 to 38.4) 38.4 (38.0 to 38.5) 0.44
Leukocytes, median*103/mm3 (percentile 25 to 75) 10.6 (8.2 to 15.4) 12.6 (8.5 to 19.5) 0.01
Neutrophils, median*103/mm3 (percentile 25 to 75) 8.2 (5.9 to 12.6) 10.0 (6.8 to 14.8) 0.18
Pa02/FI02 ratio, median (percentile 25 to 75) 225 (177 to 294) 190 (110 to 331) 0.26
Platelets, median*103/mm3 (percentile 25 to 75) 225 (116 to 317) 187 (63 to 217) 0.16
aPTT, seconds, median (percentile 25 to 75) 29 (26 to 30) 31 (27 to 34) 0.61
International normalized ratio, median (percentile 25 to 75) 1.1 (1.0 to 1.2) 1.1 (1.0 to 1.1) 0.86
SOFA score, median (percentile 25 to 75) 5 (4 to 8) 8 (5 to 13) <0.001
Lactic acid, mmol/L, median (percentile 25 to 75) 1.2 (0.9 to 1.6) 1.7 (1.0 to 2.3) <0.001
Bilirubin, mg/dl, median (percentile 25 to 75) 0.6 (0.4 to 0.9) 0.7 (0.3 to 2.3) 0.40
Creatinine, mg/dl, median (percentile 25 to 75) 0.8 (0.6 to 1.4) 0.7 (0.5 to 1.0) 0.57
CVC decision at moment of CRI suspicion, n (%) 0.26
CVC removal without new catheter 28 (9.0) 6 (8.2)
CVC removal with new catheter 140 (45.0) 40 (54.8)
Watchful waiting without conservative cultures for diagnosis of CRBSI 99 (31.8) 15 (20.5)
Watchful waiting with conservative cultures for diagnosis of CRBSI 44 (14.1) 12 (16.4)
Moment of CVC removal, n (%) 0.31
No CVC removal 96 (30.9) 20 (27.4)
CVC removal at moment of CRI suspicion 168 (54.0) 46 (63.0)
CVC removal later at moment of CRI suspicion 47 (15.1) 7 (9.6)
Cause of symptomatology, n (%) 0.03
CRBSI 45 (14.5) 3 (4.1)
Pneumonia 69 (22.2) 32 (43.8)
Tracheobronchitis 53 (17.0) 7 (9.6)
Urinary infection 22 (7.1) 5 (6.8)
Skin infection 15 (4.8) 6 (8.2)
Osteomyelitis 2 (0.6) 0
Central nervous system infection 3 (1.0) 1 (1.4)
Abdominal infection 22 (7.1) 5 (6.8)
Otitis 1 (0.3) 0
Non-infectious 5 (1.6) 2 (2.7)
Unknown 74 (23.8) 12 (16.4)
CRBSI as cause of symptomatology, n (%) 45 (14.5) 3 (4.1) 0.02
PaO2/FIO2, pressure of arterial oxygen/fraction inspired of oxygen; aPTT, activated partial thromboplastin time; SOFA, sepsis-related organ failure assessment; CVC,
central venous catheter; CRI, catheter-related infection; CRBSI, catheter-related bloodstream infection.
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CRBSI and the group of patients whose clinical symptoms
were due to other causes. Table 2 shows higher risk of
mortality in patients with immediate CVC removal on
suspicion of CRI, compared with later removal of CVC
(OR 3.97, 95% CI 1.30, 12.10; P =0.02).
ICU may be a confounder for the association between
moment of CVC removal and mortality. However, in the
chi squared test between ICU and mortality, χ2 was 27.1
(degrees of freedom 17; P =0.057). Thus, ICU cannot be
considered a confounder for the association between
moment of CVC removal and mortality.
Table 3 shows comparisons of demographic and clinical
parameters of patients with CRBSI confirmed according
to immediate CVC removal on suspicion of CRI (n =38)
or later (n =10). The group with immediate CVC removal
had higher aPTT and rates of diabetes mellitus. We did
not find statistically significant differences in mortality
between the two groups (7.9% versus 0; P =0.99).
New CVCs were placed in 303 patients as follows: 162
subclavian, 61 femoral, and 59 jugular catheters, and 21
peripherally inserted central catheters (PICC). We recor-
ded two cases of pneumothorax in 162 patients with
subclavian access (1.2%), without death.
Regarding the cause of CRBSI, we found 32 Gram-
positive coccus, 15 Gram-negative bacilli and one yeast.
The microorganisms responsible for CRBSI were as
follows: four Staphylococus aureus, nineteen coagulase-
negative Staphylococcus spp., one Streptococcus pyogenes,Table 2 Logistic regression model to predict survival at
30 days
Odds ratio 95% Confidence
interval
P-value
Moment of CVC removal - - 0.04
CVC removal immediately




on CRI suspicion versus
3.97 1.30, 12.10 0.02
CVC removal later
No CVC removal versus 1.42 0.76, 2.65 0.27
CVC removal later





Propensity score 2 0.001 (0.0001, 0.07) 0.001
(Reference category:
no cvc removal)
CVC removal later at
moment of CRI suspicion
CVC, central venous catheter; CRI, catheter-related infection.one Streptococcus viridans, five Enterococcus faecalis, two
Enterococcus faecium, one Escherichia coli, two Klebsiella
spp., one Enterobacter spp., one Serratia marcescens, seven
Pseudomonas aeruginosa, three Acinetobacter spp., and
one Candida glabrata. Two patients with CRBSI due to
coagulase-negative Staphylococus spp., and one due to
E. faecalis had died at 30 days of suspected CRI.
Discussion
The most interesting findings of our study were that
CRBSI was confirmed in only 12% of patients with sus-
pected CRI, that mortality due to CRBSI was lower than
that due to other causes explaining the clinical symptoms,
that the group of patients with immediate CVC removal
on suspicion of CRI showed a higher rate of mortality at
30 days of suspected CRI than the group with later CVC
removal, and in patients with confirmed CRBSI there was
no difference in mortality between immediate or later
CVC removal on suspicion of CRI.
In our study, an infection was the cause of the clinical
symptoms in 76% of cases. This percentage is higher
than those in previous series reporting that infectious
events were the cause of fever in critically ill patients,
ranging between 17% [11] and 50% [12-14] of cases. We
found that CRBSI was confirmed in 12% of cases with
suspected CRI. This rate in our study could be due to
the implementation of the Spanish Bacteremia Zero
project [6]. After the previous success of the program
pioneered by the Johns Hopkins Quality and Safety
Research Group in Michigan (Keystone ICU project)
which was associated with a dramatic and sustained re-
duction of CRBSI [5], the Bacteremia Zero project aimed
to assess its effectiveness after contextual adaptation and
large-scale implementation in Spanish ICUs. In 2008, a
collaborative agreement of the Spanish Ministry of Health,
Social Policy and Equality, the Patient Safety Programme
of the World Health Organization (WHO), the Spanish
Society of Intensive and Critical Care Medicine and
Coronary Units (SEMICYUC), and the Johns Hopkins
Quality and Safety Research Group (now the Armstrong
Institute for Patient Safety and Quality) was estab-
lished to implement the Keystone project in Spanish
ICUs. CRBSI was reduced from 3.07 to 1.12 episodes
per 1,000 catheter-days.
One interesting finding of our study was that mortality
due to CRBSI was lower than that in the group of patients
whose clinical symptoms were explained by another cause
(6.25% versus 20.8%). Another interesting finding was that
there were no differences between survivors and non-
survivors in terms of CVC decision and moment of CVC
removal, nor in mortality between immediate CVC re-
moval on suspicion of CRI or later in patients with
confirmed CRBSI. These findings are in consonance
with the results of the study by Rijnders et al. [7]. In that
Table 3 Characteristics of patients with CRBSI according to moment of CVC removal
Data CVC removed at moment of
suspicion of CRI (n =38)
CVC removed later after
suspicion of CRI (n =10)
P-value
Age, years, median (percentile 25 to 75) 63 (53 to 72) 57 (49 to 64) 0.30
Sex, female, n (%) 11 (28.9) 5 (50.0) 0.27
Admission diagnostic, n (%) 0.10
Medical 20 (52.6) 8 (80.0)
Surgical 17 (44.7) 1 (10.0)
Traumatology 1 (2.6) 1 (10.0)
Diabetes mellitus, n (%) 8 (21.6) 6 (60.0) 0.04
COPD, n (%) 5 (13.2) 2 (20.0) 0.63
Corticosteroids, n (%) 10 (26.3) 3 (30.0) 0.99
Antibiotics, n (%) 28 (73.7) 6 (60.0) 0.45
Tracheostomy, n (%) 12 (31.6) 2 (20.0) 0.70
Temperature, °C, median (percentile 25 to 75) 38.2 (37.9 to 38.8) 38.1 (37.5 to 38.5) 0.32
Leukocytes, median*103/mm3 (percentile 25 to 75) 12.5 (8.9 to 16.5) 14.6 (6.9 to 20.1) 0.68
Neutrophils, median*103/mm3 (percentile 25 to 75) 8.6 (6.1 to 13.1) 11.0 (4.6 to 14.4) 0.77
Pa02/FI02 ratio, median (percentile 25 to 75) 271 (200 to 320) 260 (190 to 347) 0.96
Platelets, median*103/mm3 (percentile 25 to 75) 192 (130 to 299) 191 (110 to 378) 0.99
aPTT, seconds, median (percentile 25 to 75) 32 (28 to 38) 26 (25 to 27) 0.03
INR, median (percentile 25 to 75) 1.09 (1.01 to 1.20) 1.20 (1.10 to 1.24) 0.11
SOFA score, median (percentile 25 to 75) 6 (2 to 8) 4 (3 to 6) 0.61
Lactic acid, mmol/L, median (percentile 25 to 75) 1.28 (0.95 to 1.60) 1.40 (0.88 to 2.47) 0.65
Bilirubin, mg/dl, median (percentile 25 to 75) 1.0 (0.6 to 2.9) 0.6 (0.4 to 1.3) 0.25
Creatinine, mg/dl, median (percentile 25 to 75) 0.9 (0.6 to 1.3) 1.3 (0.6 to 1.9) 0.39
Mortality, n (%) 3 (7.9) 0 0.99
COPD, chronic obstructive pulmonary disease; PaO2/FIO2, pressure of arterial oxygen/fraction inspired of oxygen; aPTT, activated partial thromboplastin time; INR,
international normalized ratio; SOFA, sepsis-related organ failure assessment; CVC, central venous catheter; CRBSI, catheter-related bloodstream infection.
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pected CRI, the authors compared the outcomes of pa-
tients with early removal of short-term CVC or watchful
waiting. There were no differences in mortality, duration
of ICU stay or resolution of fever between the two groups
of patients. However, in the early removal group all cathe-
ters were removed and in the watchful waiting group only
38% catheters were removed.
We found a low rate of mechanical complications
during new puncture for vascular catheterization. Only
1.2% presented with pneumothorax due to catheterization
of the subclavian vein, and this rate is within the 0 to 6%
range previously published [8].
Taking into account all the above findings, we believe
that in patients with haemodynamic stability, and with-
out history of immunosuppressive disease or therapy,
intravascular foreign body or transplanted organ, and
without suppuration/inflammation at the insertion site
or bacteraemia/fungemia, the immediate CVC removal
may be unnecessary when CRI is suspected. And if none
of these conditions are present, the strategy of watchful
waiting for microbiological results before CVC removalcould be adopted. This approach is in consonance with
the opinion of other authors [15].
In addition, we believe the decision on immediate
CVC removal or watchful waiting in patients with sus-
pected CRI should take into account the following aspects
for each patient: first, vascular accessibility, as new vascu-
lar catheterization may be very difficult in some cases due
to poor vascular access; second, the risk of mechanical
complications during new canalization that may even be
life-threatening (for example, patients with coagulopathy
or severe respiratory disease); third, the possibility that the
CVC may not be the origin of the suspected CRI. In this
regard, CVCs placed in the jugular vein of tracheosto-
mized patients [16] or those placed in the femoral
vein present a higher risk of CRBSI [17]; however, the
risk of CRBSI decreases with the use of antimicrobial-
impregnated catheters [18] and dressings [19].
The strengths of our study are that it was a multicen-
tre study (which increases the applicability of its results
to other ICUs) and the larger sample size compared with
the study by Rijnders et al. (384 versus 64 episodes of
suspected CRI) [7]. However, it has certain limitations.
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ful waiting was not subject to random assignment. The
decision on which strategy to adopt was made by the pa-
tient’s physician in all cases; however, we tried to control
for this limitation with a propensity analysis. Second,
some patients were excluded and it could be interesting
to analyze optimal clinical practice in these patients.
Third, we have not reported the proportion of ICU pa-
tients with central venous catheters who were excluded.
Conclusion
In patients with suspected CRI, immediate CVC removal
may be unnecessary if the patient does not have a trans-
planted organ, intravascular foreign body, haemodynamic
instability, immunosuppressive disease or therapy, suppur-
ation or inflammation at the insertion site, or bacteraemia
or fungemia. Other aspects should be taken into account
in the decision-making, such as vascular accessibility, the
risk of mechanical complications during new cannulation
that may be life-threatening, and the possibility that the
CVC may not be the origin of the suspected CRI.
Key messages
 Mortality due to CRBSI was lower than that due to
other causes explaining the clinical symptoms
 We did not find significant differences in mortality
in patients with confirmed CRBSI according to
immediate CVC removal on suspicion of
CRI or later
 In patients with suspected CRI, immediate CVC
removal may be unnecessary
 Other aspects should be taken into account in the
decision-making
Abbreviations
aPTT: activated partial thromboplastin time; COPD: chronic obstructive
pulmonary disease; CRBSI: catheter-related bloodstream infection;
CRI: catheter-related infection; CVC: central venous catheter; IDSA: Infectious
Diseases Society of America; INR: international normalized ratio; PaO2/
FIO2: pressure of arterial oxygen/fraction inspired of oxygen; SOFA:
sepsis-related organ failure assessment.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LL has designed the study and drafting the manuscript. LL, MMM, PV, SR,
MIO and JSV have participated in the acquisition of data. LL has made the
analysis and interpretation of data. All authors have revised the manuscript
critically and approved the final version of manuscript for publication.
Acknowledgements
This study was supported, in part, by grants from Instituto de Salud Carlos III
(I3SNS-INT-11-063 and I3SNS-INT-12-087) (Madrid, Spain) and co-financed by
Fondo Europeo de Desarrollo Regional (FEDER). The funding agencies had
no role in the study design, in the collection, analysis, and interpretation of
the data, in the writing of the manuscript or in the decision to submit the
manuscript for publication. Investigators of the Working Group on Catheter
Related Infection Suspicion Management of Grupo de Trabajo deEnfermedades Infecciosas y Sepsis de la Sociedad Española de Medicina
Intensiva, Crítica y Unidades Coronarias (GTEIS/SEMICYUC): Leonardo Lorente,
Lorena Raja, Ruth Santacreu, Alejandro Jiménez (Hospital Universitario de
Canarias, La Laguna, Santa Cruz de Tenerife, Spain); María M Martín, Sergio T
Rodríguez (Hospital Universitario Nuestra Señora Candelaria, Santa Cruz
Tenerife, Spain); Pablo Vidal (Complexo Hospitalario Universitario de Ourense,
Ourense, Spain); Sergio Rebollo, Agueda Ojados (Hospital General Universitario
Santa Lucía, Cartagena, Murcia, Spain); María I Ostabal (Hospital Miguel Servet,
Zaragoza, Spain); Jordi Solé-Violán, José M Ferrer (Hospital Universitario
Dr Negrín, Las Palmas de Gran Canaria, Spain); Enrique Alemparte, Ana Ortega
(Hospital de Montecelo-Complejo Hospitalario de Pontevedra, Pontevedra,
Spain); Salomé Palmero, Nuria Medina (Hospital Quirón Tenerife, Santa Cruz de
Tenerife, Spain); Montserrat Vallverdu, Silvia Iglesias (Hospital Universitario
Arnau Vilanova, Lleida, Spain); Blanca López, María C Martín (Hospital del Tajo,
Aranjuez, Madrid, Spain); Andrey Rodríguez, Jordi Valles (Corporació Sanitària
Universitària Parc Taulí, Sabadell, Barcelona, Spain); Sonia Gómez-Rosado, Teresa
Honrubia (Hospital Universitario de Móstoles, Móstoles, Madrid, Spain); Francisca
Prieto (Hospital Santa Barbara, Puertollano, Ciudad Real, Spain); Alejandro
Rodríguez, Mireia Llauradó (Hospital Joan XXIII, Tarragona, Spain); Pau Garro,
Pamela Saenz (Hospital General de Granollers, Granollers, Barcelona, Spain);
Carmen J. Fernández (Complejo Hospitalario Arquitecto Marcide, Ferrol,
A Coruña, Spain); Raquel Moreno (Hospital Infanta Sofía, San Sebastián de los
Reyes, Madrid, Spain); Miguel Rodriguez, Ricard Jordà (Clínica Rotger, Palma de
Mallorca, Spain).
Author details
1Intensive Care Unit, Hospital Universitario de Canarias, Ofra s/n, La Laguna,
Santa Cruz de Tenerife 38320, Spain. 2Intensive Care Unit, Hospital
Universitario Nuestra Señora Candelaria, Carretera Rosario s/n, Santa Cruz
Tenerife 38010, Spain. 3Intensive Care Unit, Complexo Hospitalario
Universitario de Ourense, C/ Ramon Puga Noguerol n°54, Ourense 32005,
Spain. 4Intensive Care Unit, Hospital General Universitario Santa Lucía, C/
Mezquita s/n, Paraje Los Arcos, Cartagena, Murcia 30202, Spain. 5Intensive
Care Unit, Hospital Miguel Servet, Paseo Isabel la Catolica n° 1-3, Zaragoza
50009, Spain. 6Intensive Care Unit, Hospital Universitario Dr. Negrín, CIBERES,
Barranco de la Ballena s/n, Las Palmas de Gran Canaria 35010, Spain.
Received: 21 April 2014 Accepted: 1 October 2014
References
1. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II,
Rijnders BJ, Sherertz RJ, Warren DK: Clinical practice guidelines for the
diagnosis and management of intravascular catheter-related infection:
2009 Update by the Infectious Diseases Society of America. Clin Infect Dis
2009, 49:1–45.
2. Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, Agodi
A, Frank U, Mertens K, Schumacher M, Wolkewitz M: Clinical outcomes of
health-care-associated infections and antimicrobial resistance in patients
admitted to European intensive-care units: a cohort study. Lancet Infect
Dis 2011, 11:30–38.
3. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N:
Treatment and outcome of Staphylococcus aureus bacteremia: a
prospective study of 278 cases. Arch Intern Med 2002, 162:25–32.
4. O'Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P,
Maki DG, Nierman D, Pasculle W, Masur H, American College of Critical Care
Medicine; Infectious Diseases Society of America: Guidelines for evaluation
of new fever in critically ill adult patients: 2008 update from the
American College of Critical Care Medicine and the Infectious Diseases
Society of America. Crit Care Med 2008, 36:1330–1349.
5. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S,
Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C:
An intervention to decrease catheter-related bloodstream infections in
the ICU. N Engl J Med 2006, 355:2725–2732.
6. Palomar M, Álvarez-Lerma F, Riera A, Díaz MT, Torres F, Agra Y, Larizgoitia I,
Goeschel CA, Pronovost PJ, Bacteremia Zero Working Group: Impact
of a national multimodal intervention to prevent catheter-related
bloodstream infection in the ICU: the Spanish experience. Crit Care Med
2013, 41:2364–2372.
7. Rijnders BJ, Peetermans WE, Verwaest C, Wilmer A, Van Wijngaerden E:
Watchful waiting versus immediate catheter removal in ICU patients
Lorente et al. Critical Care 2014, 18:564 Page 8 of 8
http://ccforum.com/content/18/5/564with suspected catheter-related infection: a randomized trial.
Intensive Care Med 2004, 30:1073–1080.
8. Lorente L, León C: Femoral venous catheterization. Does it really need to
be avoided? Med Intensiva 2009, 33:442–449.
9. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM,
Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME,
Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS,
Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R,
Surviving Sepsis Campaign Guidelines Committee including the Pediatric
Subgroup: Surviving sepsis campaign: international guidelines for
management of severe sepsis and septic shock: 2012. Crit Care Med 2013,
41:580–637.
10. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H,
Reinhart CK, Suter PM, Thijs LG, for the Working Group on Sepsis-related
Problems of the European Society of Intensive Care Medicine: The
Sepsis-related Organ Failure Assessment (SOFA) score to describe organ
dysfunction/failure. Intensive Care Med 1996, 22:707–710.
11. Laupland KB, Shahpori R, Kirkpatrick AW, Ross T, Gregson DB, Stelfox HT:
Occurrence and outcome of fever in critically ill adults. Crit Care Med
2008, 36:1531–1535.
12. Circiumaru B, Baldock G, Cohen J: A prospective study of fever in the
intensive care unit. Intensive Care Med 1999, 25:668–673.
13. Barie PS, Hydo LJ, Eachempati SR: Causes and consequences of fever
complicating critical surgical illness. Surg Infect (Larchmt) 2004, 5:145–159.
14. Peres Bota D, Lopes Ferreira F, Mélot C, Vincent JL: Body temperature
alterations in the critically ill. Intensive Care Med 2004, 30:811–816.
15. O'Grady NP, Chertow DS: Managing bloodstream infections in patients
who have short-term central venous catheters. Cleve Clin J Med 2011,
78:10–17.
16. Lorente L, Jiménez A, Martín MM, Castedo J, Galván R, García C, Brouard MT,
Mora ML: Influence of tracheostomy on the incidence of central
venous catheter-related bacteremia. Eur J Clin Microbiol Infect Dis 2009,
28:1141–1145.
17. Lorente L, Henry C, Martín MM, Jiménez A, Mora ML: Central venous
catheter-related infection in a prospective and observational study of
2595 catheters. Crit Care 2005, 9:631–635.
18. Lorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A: The use of
rifampicin-miconazole-impregnated catheters reduces the incidence of
femoral and jugular catheter-related bacteremia. Clin Infect Dis 2008,
47:1171–1175.
19. Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S,
Herault MC, Haouache H, Calvino-Gunther S, Gestin B, Armand-Lefevre L,
Leflon V, Chaplain C, Benali A, Francais A, Adrie C, Zahar JR, Thuong M, Arrault
X, Croize J, Lucet JC, Dressing Study Group: Chlorhexidine-impregnated
sponges and less frequent dressing changes for prevention of
catheter-related infections in critically ill adults: a randomized
controlled trial. JAMA 2009, 301:1231–1241.
doi:10.1186/s13054-014-0564-3
Cite this article as: Lorente et al.: Should central venous catheter be
systematically removed in patients with suspected catheter related
infection? Critical Care 2014 18:564.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
